Endocannabinoid brain system involvement in dopamine mechanisms of behavioural sensitization to psychostimulants;Zapojení endokanabinoidního systému v dopaminových mechanismech rozvoje behaviorální senzitizace k psychostimulanciím

Acta Veterinaria Brno

Volumn 78, Issue 3, 2009, Pages 491-496

  Vršková, Dagmar ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Behavioural sensitization; Dopamine; Endocannabinoid system; Methamphetamine; Review

Indexed keywords

RATTUS;

EID: 70350212606     PISSN: 00017213     EISSN: None     Source Type: Journal    
DOI: 10.2754/avb200978030491     Document Type: Article

References (44)

1. Barlett E, Hallin A, Chapman B, Angrist B 1997: Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacol 16: 77-82
2. Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G 2001: Behavioural sensitization after repeated exposure to 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 158: 259-266
3. Cador M, Bjijou Y, Stinus L 1995: Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioural sensitization to amphetamine. Neuroscience 65: 385-395
4. Costa FG, Frussa-Filho R, Felicio FL 2001: The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice. Eur J Pharmacol 428: 97-103
5. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ 1999: Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology 143: 254-260
6. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ 2002: Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacol 26: 18-26
7. Devane WA, Hanus L, Breuer A 1992: Isolation and structure of a brain constituent that binds to the cannabimoid receptor. Science 258: 1946-1949
8. Di Chiara G 1995: The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Dependence 38: 95-137
9. Elliot EE 2002: Cocaine sensitization in the mouse using a cumulative dosing regime. Behav Pharmacol 13: 407-415
10. Emmett-Oglesby MW 1995: Sensitization and tolerance to the motivational and subjective effects of psychostimulants. In: Hammer RT (ed.) The Neurobiology of Cocaine: Cellular and Molecular Mechanisms, CRC Press, Boca Raton, pp. 31-47
11. Gorriti MA, Rodriguez DE, Fonseca F, Navarro M, Palomo T 1999: Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine on rats. Eur J Pharmacol 365: 133-142
12. Hanus L, Abu-Lafi S, Fride E 2001: 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98: 3662-3665
13. Kalivas PW, Stewart J 1991: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16: 223-244
14. Kalivas PW, Sorg BA, Holka MS 1993: The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4: 315-334
15. Kalivas PW, Duffy P, White SR 1998: MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacol 18: 469-479
16. Lamarque S, Taghzouti K, Simon H 2001: Chronic treatment with Delta(9) - tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Neuropharmacology 41: 118-129
17. Landa L, Jurajda M 2007a: Behavioural sensitization to methamphetamine affects expression of cannabinoid CB1 receptors in mouse midbrain. Behavi Pharmacol 18, Suppl. 1: S27-S28
18. Landa L, Jurajda M 2007b: Acute and repeated exposure to methamphetamine changes expression of CB1 receptor in mesencephalon of the mouse brain. Eur Neuropsychopharmacol 17, Suppl. 4: S557
19. Landa L, Slais K, Sulcova A 2004: Cross-sensitization with morphine to methamphetamine effects on locomotion in mice. Homeostasis 43: 43-44
20. Landa L, Slais K, Hanesova M, Sulcova A 2005: Interspecies comparison of sensitization to methamphetamine effects on locomotion in mice and rats. Homeostasis 43: 146-147
21. Landa L, Slais K, Sulcova A 2006a: Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice. Neuroendocrinol Lett 27: 63-69
22. Landa L, Slais K, Sulcova A 2006b: Impact of cannabinoid receptor ligands on behavioural sensitization to antiaggressive methamphetamine effects in the model of mouse agonistic behaviour. Neuroendocrinol Lett 27: 703-710
23. Landa L, Slais K, Sulcova A 2008: Impact of cannabinoid receptor ligands on sensitization to metamphetamine effects on rat locomotor behaviour. Acta Vet Brno 77: 183-191
24. Lanis A, Schmidt WJ 2001: NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependent. Behav Pharmacol 12: 143-149
25. Laviola G, Adriani W, Terranova ML, Gerra G 1999: Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev 23: 993-1010
26. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI 1990: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564
27. Mechoulam R, Fride E, Di Marzo V 1998: Endocannabinoids. Eur J Pharmacol 359: 1-18
28. Moss DE, Koob GF, McMaster SB, Janowsky DS 1984: Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors. Pharmacol Biochem Behav 21: 641-644
29. Munro S, Thomas KL, Abu-Shaar M 1993: Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65
30. Ohmori T, Abekawa T, Ito K, Koyama T 2000: Context determines the type of sensitized behaviour: a brief review and a hypothesis on the role of environment in behavioural sensitization. Behav Pharmacol 11: 211-221
31. Pertwee RG 1997: Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129-180
32. Pertwee RG 1999: Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6: 635-664
33. Pertwee RG 2000: Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin Inv Drug 9: 1553-1571
34. Pierce RC, Kalivas PW 1997: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25: 192-216
35. Robinson TE, Berridge KC 1993: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18: 247-291
36. Shoaib M, Stolerman IP, Kumar RC 1994: Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology (Berl) 113: 445-452
37. Strakowsky SM, Sax KW, Setters MJ, Keck JR PE 1996: Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiat 40: 872-880
38. Vanderschuren LJ, De Vries TJ, Wardeh G, Hogenboom FA, Schoffelmeer AN 2001: A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci 14: 1533-1538
39. Vezina P, Stewart J 1990: Amphetamine administered to the ventral tegmental area but not to the nucleus- accumbens sensitizes rats to systemic morphine-lack of conditioned effects. Brain Res 516: 99-106
40. Vinklerova J, Novakova J, Sulcova A 2002: Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J Psychopharmacol 16: 139-143
41. Von Bohlen und Halbach O, Dermietzel R 2002: Neurotransmitters and Neuromodulators. Handbook of Receptors and Biological Effects, Wiley-VCH Verlag GmbH, Weinheim
42. Votava M, Krsiak M, Moravec V 2002: Effects of alprazolam and fluoxetine on morphine sensitization in mice. Physiol Res 51: 417-423
43. Wise RA, Bozarth MA 1987: A psychomotor stimulant theory of addiction. Psychological Rev 94: 469-492
44. Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Antony RA, Wickham D, Kish SJ 2000: Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Molec Psychiatry 5: 664-672